Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Latest filing published 14 May 2026 for Ligand Pharmaceuticals INC, €16k. Read the official filing
Filing timeline
BuySaleJohn W. Kozarich
Insider track record
Disclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John W. Kozarich: trading record in brief
John W. Kozarich (senior executive) discloses dealings in Ligand Pharmaceuticals Inc to SEC (Form 4). In total, 32 filings cover trades dated from 20 January 2016 to 1 May 2026.
The open-market record consists of 21 sales worth €654k, with no purchase. No amount is published for 5 filings, which the totals therefore leave out. Other entries cover 5 share grants and 6 option exercises. 2026 to date brings no purchases and 9 sales.
On 14 May 2026 came the latest disclosure, an open-market sale for €16k in Ligand Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John W. Kozarich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
80 shares@ US$227.36750.0004% mcap8.0% of flowCommon StockSEC:0002001011-26-000049:0
159 shares@ US$204.26273.2% of flowCommon StockSEC:0002001011-26-000038:4
146 shares@ US$199.97492.9% of flowCommon StockSEC:0002001011-26-000038:0
40 shares@ US$201.2350.8% of flowCommon StockSEC:0002001011-26-000038:1
79 shares@ US$202.42231.6% of flowCommon StockSEC:0002001011-26-000038:2
43 shares@ US$202.91220.9% of flowCommon StockSEC:0002001011-26-000038:3
47 shares@ US$197.13970.7% of flowCommon StockSEC:0002001011-26-000018:0
39 shares@ US$191.000.6% of flowCommon StockSEC:0002001011-26-000007:0
21 shares@ US$186.590.3% of flowCommon StockSEC:0002001011-26-000004:0
92 shares@ US$193.85771.4% of flowCommon StockSEC:0002001011-25-000113:0
84 shares@ US$188.99681.3% of flowCommon StockSEC:0002001011-25-000096:0
24 shares@ US$177.60480.3% of flowCommon StockSEC:0002001011-25-000093:0
267 shares@ US$161.51353.5% of flowCommon StockSEC:0002001011-25-000068:0
467 shares@ US$131.87555.2% of flowCommon StockSEC:0002001011-25-000059:0
934 shares@ US$125.0010.3% of flowCommon StockSEC:0002001011-25-000053:0
1,209 shares0Common StockSEC:0002001011-25-000041:0
2,406 shares@ US$52.3015.4% of flowCommon StockSEC:0002001011-25-000036:0
1,252 shares0Common StockSEC:0002001011-24-000058:0
2,893 shares@ US$39.3514.7% of flowCommon StockSEC:0002001011-24-000048:0
1,142 shares0Common StockSEC:0000886163-23-000041:0
4,444 shares@ US$77.200943.5% of flowCommon StockSEC:0000899243-23-013275:0
6,408 shares@ US$18.8215.1% of flowCommon StockSEC:0000899243-23-012541:0
1,004 shares0Common StockSEC:0000886163-22-000080:0
7,335 shares@ US$12.530.0022% mcap42.4% of flowCommon StockSEC:0000886163-22-000033:0
630 shares0Common StockSEC:0000886163-21-000090:0
25 of 32 declarations
